Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

20-Dec-19 - 17-Dec-20
Buy Ratio:33%

Down

# Net Buyers:84
# Net Sellers:171

Previous 52 Weeks

21-Dec-18 - 19-Dec-19
Buy Ratio:39%
# Net Buyers:111
# Net Sellers:176
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.--$3.37B  
Loxo Oncology, Inc.--$561.91M  
Aimmune Therapeutics, Inc.$290.13M$290.42M  
Osiris Therapeutics, Inc.--$281.65M  
Spark Therapeutics, Inc.--$256.00M  
New Net Buyers
CompanyNet Buy AmountChange
Aimmune Therapeutics, Inc.$290.13M$290.42M  
Vertex Pharmaceuticals Inc / Ma$4.44M$113.55M  
Alexion Pharmaceuticals, Inc.$536.91K$45.19M  
Kalvista Pharmaceuticals, Inc.$413.78K$36.06M  
Charles River Laboratories International, Inc.$477.99K$34.54M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals, Inc.($1.14B)($823.67M)  
Seagen Inc.($601.21M)($557.05M)  
Catalent, Inc.($578.43M)($550.20M)  
Vaxart, Inc.($322.59M)($325.21M)  
Five Prime Therapeutics, Inc.($145.22M)($155.79M)  
New Net Sellers
CompanyNet Buy AmountChange
Vaxart, Inc.($322.59M)($325.21M)  
Five Prime Therapeutics, Inc.($145.22M)($155.79M)  
Intercept Pharmaceuticals, Inc.($124.12M)($124.61M)  
Acceleron Pharma Inc($14.39M)($39.67M)  
Cytokinetics Inc($36.66M)($39.29M)